| Descriptor English: | Thiabendazole |
| Descriptor Spanish: | Tiabendazol |
| Descriptor Portuguese: | Tiabendazol |
| Descriptor French: | Tiabendazol |
| Entry term(s): |
2-(4'-Thiazolyl)Benzimidazole Mintesol Mintezol Omnizole Thibendole Tiabendazol |
| Tree number(s): |
D02.886.675.840 D03.383.129.708.824 D03.633.100.103.850 |
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D013827 |
| Scope note: | 2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for STRONGYLOIDIASIS. It has CENTRAL NERVOUS SYSTEM side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919) |
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
| Pharm Action: |
Anthelmintics |
| Registry Number: | N1Q45E87DT |
| CAS Type 1 Name: | 1H-Benzimidazole, 2-(4-thiazolyl)- |
| Public MeSH Note: | 65 |
| History Note: | 65(63) |
| DeCS ID: | 14204 |
| Unique ID: | D013827 |
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents |
| Date Established: | 1965/01/01 |
| Date of Entry: | 1999/01/01 |
| Revision Date: | 2016/06/01 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Thiabendazole
- Preferred
Mintezol
- Narrower
Omnizole
- Narrower
Mintesol
- Narrower
| Concept UI |
M0021313 |
| Scope note | 2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for STRONGYLOIDIASIS. It has CENTRAL NERVOUS SYSTEM side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919) |
| Preferred term | Thiabendazole |
| Entry term(s) |
2-(4'-Thiazolyl)Benzimidazole Thibendole Tiabendazol |
| Concept UI |
M0021314 |
| Preferred term | Mintezol |
| Concept UI |
M0353570 |
| Preferred term | Omnizole |
| Concept UI |
M0353571 |
| Preferred term | Mintesol |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
